Amjevita (Adalimumab)

Amjevita is called Amgevita in UK.

Information about Amjevita (Adalimumab)

Amjevita is used to treat various inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, and plaque psoriasis. It works by reducing inflammation in the body.

Amjevita may be prescribed either alone or with methotrexate or other non-biologic disease-modifying anti-rheumatic drugs (DMARDs).

Amjevita is prescribed to reduce signs and symptoms in adults with active ankylosing spondylitis.

Product Highlights

• Amjevita is a biosimilar to adalimumab, which means it is highly similar to the original biologic medicine but produced by a different manufacturer. 
• It provides a cost-effective alternative option for patients needing adalimumab therapy.
• Amjevita (adalimumab) is typically administered by subcutaneous injection. The specific dosage and frequency of administration depend on the condition being treated and individual patient response.

Key Ingredients

• Adalimumab Atto
• Glacial acetic acid
• Sucrose
• Polysorbate 80 and Water for Injection.

Key Benefits

• Helps alleviate symptoms of inflammation in conditions like arthritis and inflammatory bowel disease.
• Allows patients to manage chronic conditions more effectively, leading to improved overall well-being.
• Provides sustained relief from symptoms with regular use.

Direction For Use

• Amjevita (adalimumab) is supplied single use prefilled injection. It is important to follow the dosing schedule prescribed by your healthcare provider.

Safety Concern

• Amjevita can increase the risk of serious infections, including tuberculosis and fungal infections. Patients should be monitored for signs of infection during treatment.
• Some patients may experience allergic reactions to Amjevita, which can be severe. Immediate medical attention is necessary if symptoms like rash, itching, swelling, or difficulty breathing occur.
• Amjevita may cause autoimmune reactions or exacerbate existing autoimmune conditions.
• Regular monitoring by healthcare providers is essential to manage potential side effects and ensure the medication's effectiveness.

Avoid Taking Amjevita (Adalimumab) If:

• You have a known allergy to adalimumab or any of the components in the formulation.
• You have an active infection, including tuberculosis.
• You are pregnant or planning to become pregnant, as the effects of adalimumab on pregnancy are not fully known.

This product requires special packaging to maintain its integrity during the shipping process. DO NOT USE THIS MEDICATION if the attached temperature indicator shows that the medication was exposed to temperatures below 2 degrees or above 8 degrees Celsius, and contact the pharmacy immediately.